Amalgamated Bank Regeneron Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

  • $12.2 Billion
  • Q4 2024

A detailed history of Amalgamated Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 20,373 shares of REGN stock, worth $14.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
20,373
Previous 22,820 10.72%
Holding current value
$14.3 Million
Previous $24 Million 39.51%
% of portfolio
0.12%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$701.85 - $1046.91 $1.72 Million - $2.56 Million
-2,447 Reduced 10.72%
20,373 $14.5 Million
Q3 2024

Oct 30, 2024
BUY
$1024.09 - $1201.76 $1.42 Million - $1.66 Million
1,382 Added 6.45%
22,820 $24 Million
Q2 2024

Aug 12, 2024
SELL
$883.2 - $1071.19 $261,427 - $317,072
-296 Reduced 1.36%
21,438 $22.5 Million
Q1 2024

Apr 23, 2024
SELL
$902.69 - $993.35 $3.72 Million - $4.09 Million
-4,122 Reduced 15.94%
21,734 $20.9 Million
Q4 2023

Feb 06, 2024
SELL
$775.18 - $881.7 $923,239 - $1.05 Million
-1,191 Reduced 4.4%
25,856 $22.7 Million
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $442,475 - $539,552
-639 Reduced 2.31%
27,047 $22.3 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $2.11 Million - $2.5 Million
-3,012 Reduced 9.81%
27,686 $19.9 Million
Q1 2023

May 02, 2023
BUY
$680.49 - $826.97 $1.95 Million - $2.37 Million
2,867 Added 10.3%
30,698 $25.2 Million
Q4 2022

Feb 10, 2023
SELL
$705.89 - $766.39 $1.38 Million - $1.5 Million
-1,962 Reduced 6.59%
27,831 $20.1 Million
Q3 2022

Nov 09, 2022
BUY
$573.97 - $724.32 $920,647 - $1.16 Million
1,604 Added 5.69%
29,793 $20.5 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $194,115 - $261,549
354 Added 1.27%
28,189 $16.7 Million
Q1 2022

Jun 30, 2022
SELL
$595.12 - $698.43 $809,363 - $949,864
-1,360 Reduced 4.66%
27,835 $19.4 Million
Q4 2021

Feb 15, 2022
BUY
$543.48 - $670.97 $952,720 - $1.18 Million
1,753 Added 6.39%
29,195 $18.4 Million
Q3 2021

Oct 29, 2021
SELL
$574.03 - $680.96 $584,936 - $693,898
-1,019 Reduced 3.58%
27,442 $16.6 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $10.6 Million - $12.5 Million
22,413 Added 370.59%
28,461 $15.9 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $126,871 - $155,688
-284 Reduced 4.49%
6,048 $2.86 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $11,479 - $14,591
-24 Reduced 0.38%
6,332 $3.06 Million
Q3 2020

Oct 30, 2020
SELL
$544.75 - $658.21 $82,257 - $99,389
-151 Reduced 2.32%
6,356 $3.56 Million
Q2 2020

Aug 10, 2020
SELL
$493.32 - $643.92 $2.82 Million - $3.69 Million
-5,723 Reduced 46.79%
6,507 $4.06 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $152,625 - $224,471
-454 Reduced 3.58%
12,230 $5.97 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $187,230 - $257,156
683 Added 5.69%
12,684 $4.76 Million
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $134,268 - $156,329
491 Added 4.27%
12,001 $3.33 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $183,954 - $254,699
-614 Reduced 5.06%
11,510 $3.6 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $161,854 - $191,212
435 Added 3.72%
12,124 $4.98 Million
Q4 2018

Feb 15, 2019
SELL
$335.82 - $403.04 $109,813 - $131,794
-327 Reduced 2.72%
11,689 $4.37 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $128,517 - $149,514
-366 Reduced 2.96%
12,016 $4.86 Million
Q2 2018

Jul 18, 2018
BUY
$284.6 - $344.99 $231,379 - $280,476
813 Added 7.03%
12,382 $4.27 Million
Q1 2018

May 22, 2018
BUY
$315.82 - $393.78 $359,403 - $448,121
1,138 Added 10.91%
11,569 $3.98 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $361,499 - $473,709
1,008 Added 10.7%
10,431 $3.92 Million
Q3 2017

Nov 09, 2017
BUY
$431.38 - $504.0 $4.06 Million - $4.75 Million
9,423
9,423 $4.21 Million

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email